Clinical Trial Update: Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Disease [NA]

View source ↗

Summary

An update on a randomized evaluation study investigating adherence to dyslipidemia therapy in patients with atherosclerotic cardiovascular disease and diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Diabetes Mellitus

Snippet

Sponsor: Kaiser Permanente | Conditions: ASCVD, Diabetes | NA | Status: NOT_YET_RECRUITING